Pharmacokinetics of oltipraz in diabetic rats with liver cirrhosis.
about
Validated LC-MS method for simultaneous quantitation of catalpol and harpagide in rat plasma: application to a comparative pharmacokinetic study in normal and diabetic rats after oral administration of Zeng-Ye-Decoction.Pharmacokinetic changes of drugs in a rat model of liver cirrhosis induced by dimethylnitrosamine, alone and in combination with diabetes mellitus induced by streptozotocin.Pharmacokinetics of dl-praeruptorin A after single-dose intravenous administration to rats with liver cirrhosis.Pharmacokinetics of mirodenafil and its two metabolites, SK3541 and SK3544, after intravenous and oral administration of mirodenafil to streptozotocin-induced diabetes mellitus rats.Pharmacokinetic variations of tetramethylpyrazine phosphate after oral administration in hepatic precancerous mice and its hepatoprotective effects
P2860
Pharmacokinetics of oltipraz in diabetic rats with liver cirrhosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacokinetics of oltipraz in diabetic rats with liver cirrhosis.
@en
Pharmacokinetics of oltipraz in diabetic rats with liver cirrhosis.
@nl
type
label
Pharmacokinetics of oltipraz in diabetic rats with liver cirrhosis.
@en
Pharmacokinetics of oltipraz in diabetic rats with liver cirrhosis.
@nl
prefLabel
Pharmacokinetics of oltipraz in diabetic rats with liver cirrhosis.
@en
Pharmacokinetics of oltipraz in diabetic rats with liver cirrhosis.
@nl
P2093
P2860
P1476
Pharmacokinetics of oltipraz in diabetic rats with liver cirrhosis.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.2008.00105.X
P407
P577
2009-03-01T00:00:00Z